David Chiu, PharmD

Medical Lead, US Medical Affairs, Oncology, OBU Medical
AstraZeneca

Poster(s):

• (335) Patient characteristics, treatment patterns, and real-world outcomes among patients in the US with human epidermal growth factor receptor 2 (HER2)-expressing solid tumors
  Wednesday, October 29, 2025